The contraceptive implant.

Contraceptive implants provide long-acting, highly effective reversible contraception. Currently, the only subdermal implant available to women in the United States is the single rod etonogestrel implant, Implanon (N.V. Organon, Oss, the Netherlands) approved by the Food and Drug Administration in July 2006. Implanon is currently approved for 3 years of use, provides excellent efficacy throughout its use, and is easy to insert and remove. Similar to other progestin-only contraceptives, Implanon can cause irregular vaginal bleeding. Implanon has been shown to be safe to use during lactation, may improve dysmenorrhea, and does not significantly affect bone mineral density, lipid profile, or liver enzymes.
AuthorsHeather Hohmann, Mitchell D Creinin
JournalClinical obstetrics and gynecology (Clin Obstet Gynecol) Vol. 50 Issue 4 Pg. 907-17 (Dec 2007) ISSN: 1532-5520 [Electronic] United States
PMID17982333 (Publication Type: Journal Article, Review)
Chemical References
  • Contraceptive Agents, Female
  • Drug Implants
  • Acne Vulgaris (chemically induced, epidemiology)
  • Bone Density (drug effects)
  • Contraception (methods)
  • Contraceptive Agents, Female (adverse effects, pharmacology)
  • Device Removal
  • Drug Implants
  • Female
  • Humans
  • Lipid Metabolism (drug effects)
  • Liver (drug effects, physiology)
  • Menstruation Disturbances (chemically induced, epidemiology)
  • Ovarian Cysts (chemically induced, epidemiology)
  • Patient Satisfaction
  • Safety
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: